Technical Analysis for ALT - Altimmune, Inc.

Grade Last Price % Change Price Change
grade F 2.1 -3.23% -0.07
ALT closed down 3.23 percent on Wednesday, September 18, 2019, on 52 percent of normal volume. It ran into resistance at its 50 day moving average.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical ALT trend table...

Date Alert Name Type % Chg
50 DMA Resistance Bearish 0.00%
Fell Below 20 DMA Bearish 0.00%
Down 3 Days in a Row Weakness 0.00%
50 DMA Resistance Bearish -3.23%
Bearish Engulfing Bearish -3.23%
Upper Bollinger Band Touch Strength -3.23%
Fell Below 50 DMA Bearish -5.41%
Upper Bollinger Band Walk Strength -5.41%
Upper Bollinger Band Touch Strength -5.41%
Crossed Above 50 DMA Bullish -6.67%

Older signals for ALT ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Altimmune,Inc., formerly Pharmathene, Inc., is a biodefense company. The Company is focused on the development of medical counter measures against biological and chemical threats. The Company is involved in the development of two next generation anthrax vaccines. The Company's anthrax vaccines use recombinant protective antigen (rPA) manufacturing processes. The Company's product portfolio includes recombinant butyrylcholinesterase (rBChE) bioscavenger, which is used in prevention and treatment of nerve agent poisoning. The Company has developed a recombinant form of human butyrylcholinesterase for pre- and post-exposure therapy to patients with nerve agent attacks. Its rBChE bioscavenger acts with mechanism, which includes reversal of the acute toxicity associated with organophosphate poisoning agents used in chemical warfare (cholinergic crisis). Its development program also includes Valortim for monoclonal human antibody treatment.
Medicine Medical Specialties Vaccines Biological Warfare Manufacturing Processes Anthrax
Is ALT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 36.25
52 Week Low 1.7
Average Volume 186,869
200-Day Moving Average 2.6303
50-Day Moving Average 2.2194
20-Day Moving Average 2.107
10-Day Moving Average 2.15
Average True Range 0.1184
ADX 16.48
+DI 19.0522
-DI 14.7963
Chandelier Exit (Long, 3 ATRs ) 1.9348
Chandelier Exit (Short, 3 ATRs ) 2.2949
Upper Bollinger Band 2.2627
Lower Bollinger Band 1.9513
Percent B (%b) 0.48
BandWidth 14.779307
MACD Line -0.0049
MACD Signal Line -0.0211
MACD Histogram 0.0162
Fundamentals Value
Market Cap 32.39 Million
Num Shares 15.4 Million
EPS -1.51
Price-to-Earnings (P/E) Ratio -1.39
Price-to-Sales 7.62
Price-to-Book 0.53
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.28
Resistance 3 (R3) 2.30 2.26 2.25
Resistance 2 (R2) 2.26 2.21 2.25 2.24
Resistance 1 (R1) 2.18 2.19 2.16 2.16 2.23
Pivot Point 2.14 2.14 2.13 2.13 2.14
Support 1 (S1) 2.06 2.09 2.04 2.04 1.97
Support 2 (S2) 2.02 2.07 2.01 1.96
Support 3 (S3) 1.94 2.02 1.95
Support 4 (S4) 1.92